Chargement en cours...
Immune Resistance and EGFR Antagonists in Colorectal Cancer
Targeting the epidermal growth factor receptor (EGFR) either alone or in combination with chemotherapy in patients with RAS wild type metastatic colorectal cancer (mCRC) has revolutionized the treatment of CRC, but with less results than initially envisaged. In recent years, the discovery of multipl...
Enregistré dans:
| Publié dans: | Cancers (Basel) |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6721348/ https://ncbi.nlm.nih.gov/pubmed/31370270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11081089 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|